| Line Item | 2025-12-31 | Y/Y |
|---|---|---|
| Revenue | $6.5M | +150.0% |
| Cost of Revenue | $5.8M | +622.3% |
| R&D Expense | $72.7M | -10.9% |
| SG&A Expense | $43.5M | -29.3% |
| Operating Income | -$86.9M | -138.7% |
| Pre-tax Income | -$79.2M | -113.1% |
| Income Tax | $41K | -86.8% |
| Net Income | -$79.2M | -111.5% |
| EPS (Basic) | -$1.87 | -884.2% |
| EPS (Diluted) | -$1.87 | -884.2% |
| Line Item | 2025-12-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $217.0M | +289.7% |
| Accounts Receivable | $573K | -46.4% |
| Inventory | $4.5M | +59.0% |
| Current Assets | $261.6M | +133.2% |
| Total Assets | $290.5M | +98.3% |
| Current Liabilities | $25.8M | -21.7% |
| Long-term Debt | $75.0M | +0.0% |
| Total Liabilities |
| Line Item | 2025-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | -$85.6M | +34.6% |
| Investing Cash Flow | $8.2M | -87.8% |
| Financing Cash Flow | $238.6M | +1075.9% |
| $104.2M |
| -16.2% |
| Stockholders' Equity | $186.3M | +741.1% |